Amphadase

Drug overview for AMPHADASE (hyaluronidase):

Generic name: HYALURONIDASE
Drug class: Hyaluronidase Enzymes
Therapeutic class:

No enhanced Introduction information available for this drug.

No enhanced Uses information available for this drug.

DRUG IMAGES

AMPHADASE 150 UNITS/ML VIAL

The following indications for AMPHADASE (hyaluronidase) have been approved by the FDA:

Indications:
Adjunct treatment to increase absorption and dispersion of other injected drugs
Hypodermoclysis
Subcutaneous urography adjunct for contrast resorption

Professional Synonyms:
None.

Moderate List
No disease contraindications

The following adverse reaction information is available for AMPHADASE (hyaluronidase):

Overview
Severe
Less Severe

Adverse reaction overview.

No enhanced Common Adverse Effects information available for this drug.

There are 2 severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Angioedema Urticaria

There are 2 less severe adverse reactions.

More Frequent	Less Frequent
Injection site sequelae	None.

Rare/Very Rare
Edema

The following precautions are available for AMPHADASE (hyaluronidase):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

No enhanced Geriatric Use information available for this drug.